1.Esophageal Atresia with Tracheoesophageal Fistula: Clinical experience of 20 cases.
Soo Bog CHUNG ; Kyu Hyung CHOE ; Yu Yong KIM ; Eun Myong CHANG
Journal of the Korean Surgical Society 1997;52(3):393-401
No abstract available.
Esophageal Atresia*
;
Tracheoesophageal Fistula*
2.Immunogenicity and reactogenicity of a yeast recombinant DNA hepatitis B vaccine in healthy subjects.
Kyo Myong KIM ; Sang Eun CHU ; Hae Ran LEE ; Hae Sun YOON ; Kyu Man LEE ; Chang Hong MIN
Journal of the Korean Society for Microbiology 1991;26(6):493-498
No abstract available.
DNA, Recombinant*
;
Hepatitis B Vaccines*
;
Hepatitis B*
;
Hepatitis*
;
Yeasts*
3.Sex Differences in COVID-19 Infection Fear in a Community Sample of Korean Adults Using Quantile Regression
Hyunjoo NA ; Young-Eun JUNG ; Chang PARK ; Chaerin LEE ; Moon-Doo KIM ; Won-Myong BAHK
Journal of Korean Medical Science 2023;38(4):e17-
This study aims to explore the impact of distributional changes in coronavirus disease 2019 (COVID-19) infection fear with sex differences. A quota sampling strategy was followed and 483 Korean adults were surveyed in a community sample. Self-report questionnaires were used to assess COVID-19 infection fear, depressive symptoms, and general characteristics.Quantile regression was used to explore the regression relationship of COVID-19 infection fear and an individual’s sex. There was a significant difference in COVID-19 infection fear (P= 0.001) and depression (P = 0.008) between the sexes - male and female. The differences between sexes at the 20th and 30th percentiles were significant (β = 2.04, P = 0.006; β = 1.5, P = 0.004, respectively). The results demonstrate that sex significantly predicts COVID-19 infection fear and women had significantly greater fear than men in the mild-level of COVID-19 infection fear.
4.The Results of Danazol Therapy in Patients with Chronic Immune Thrombocytopenic Purpura Who Failed with Corticosteroid Therapy.
Jae Beom LEE ; Yeung Chul MUN ; Hea Sung PARK ; Moon Young CHOI ; Hye Jung CHANG ; Kyoung Eun LEE ; Eun Mi NAM ; Soon Nam LEE ; Chu Myong SUNG
Korean Journal of Hematology 2007;42(4):353-360
BACKGROUND: Most of adult patients with chronic immune thrombocytopenic purpura (ITP) that was refractory or relapsed to high-dose corticosteroid have been treated with splenectomy as a 2nd line treatment. However, these patients may have increased morbidity and mortality according to the operation and the increased risk of infection for a lifetime after splenectomy. Despite of the above risks, 30~40% of these patients can't maintain remission. Furthermore, the remission rate after splenectomy is relatively lower in patients with corticosteroid-refractory chronic ITP than that in those patients with corticosteroid-responsiveness. We studied whether danazol, an attenuated androgen, is useful or safe as 2nd line treatment for chronic ITP instead of splenectomy and which factors are associated with the response to danazol. METHODS: Among the patients with chronic ITP who failed corticosteroid therapy in our hospital, 28 patients who received danazol as the 2nd line treatment were analyzed retrospectively. A complete response was defined that the platelet count was increased to 150 x 10(3)/microL, and a partial response was defined that the platelet count was increased above 50 x 10(3)/microL or there was an increased platelet count of more than 20 x 10(3)/microL from the pre-treatment platelet count when the platelet count was above 50 x 10(3)/microL at the time of danazol therapy. RESULTS: The median age of patients was 44 years (range: 19~67) and the number of male patients was 9 (32.1%) and the number of females was 19 (67.9%). The starting daily doses of danazol were variable from 200 to 600mg, though most of the patients were treated with 400mg daily (18 cases, 64.3%). The median duration of danazol therapy was 201.5 days (range: 13~973) and the median duration from ITP diagnosis to danazol treatment was 56 days (range: 20~2,430). Among the accrued 28 patients, 22 patients showed a response to danazol (78.5%); there were 6 patients (21.4%) with a complete response and 16 patients (57.1%) with a partial response. The median duration from danazol treatment to response was 30 days (range: 0~180). The median response duration of danazol treatment was 330 days (95% CI: 182~478) by the Kaplan-Meiyer method. For the danazol-responsive patients, 9 patients (40.9%) remained in remission and 13 patients (59.1%) relapsed. Grade 3~4 toxicity was observed in two patients and three patients stopped danazol because of adverse effects. Hepatotoxicity was the most common toxicity. CONCLUSION: Our findings suggest that danazol is a beneficial, safe choice as the 2nd line treatment for patients with chronic ITP that was refractory or relapsed to corticosteroid.
Adult
;
Danazol*
;
Diagnosis
;
Female
;
Humans
;
Male
;
Mortality
;
Platelet Count
;
Purpura, Thrombocytopenic, Idiopathic*
;
Retrospective Studies
;
Splenectomy
5.Internal Hernia in Adult Patients: Transmesenteric Hernia and Internal Hernia through a Defect of the Broad Ligament.
Sang Myong LEE ; In Kyu LEE ; Yoon Suk LEE ; Won Kyung KANG ; Chang Hyeok AHN ; Do Sang LEE ; Seung Eun JUNG ; Suk Kyun CHANG
Journal of the Korean Society of Coloproctology 2006;22(6):428-431
An internal hernia is a rare disease that causes bowel obstruction. It is difficult to diagnose because the symptoms and the signs are the same as those for other obstructive diseases of the bowel. Early diagnosis and management are essential, and early surgical management may reduce complications such as ischemia, and strangulation. We experienced two cases of internal hernias. One patient underwent a laparotomy, and had a transmesenteric defect with a herniated and strangulated small bowel segment. The other patient underwent a laparoscopic surgery, and we found that the left broad ligament had a focal defect with a herniated small bowel segment. An internal hernia is an uncommon disease, and its differentiation from other obstructive diseases of the bowel is difficult. However, the clinician should consider that the internal hernia might be the cause of the bowel obstruction, especially in patient with no previous history of intra- abdominal surgery. Early diagnosis can improve the clinical outcome through early surgery.
Adult*
;
Broad Ligament*
;
Early Diagnosis
;
Female
;
Hernia*
;
Humans
;
Ischemia
;
Laparoscopy
;
Laparotomy
;
Rare Diseases
6.Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)
Ji Hyun KIM ; Dong-eun LEE ; Yumi LEE ; Hyeong In HA ; Yoon Jung CHANG ; Suk-Joon CHANG ; Sang-Yoon PARK ; Myong Cheol LIM
Journal of Gynecologic Oncology 2022;33(4):e54-
Objective:
To investigate the health-related quality of life (HRQOL) related to hyperthermic intraperitoneal chemotherapy (HIPEC) following primary or interval cytoreductive surgery for primary ovarian cancer.
Methods:
Between 2010 and 2016, a total of 184 patients were randomly assigned to receive cytoreductive surgery with HIPEC (n=92) or without HIPEC (n=92). Quality of life (QOL) assessment was evaluated at baseline (before surgery); on postoperative day 7; after the 3rd and 6th cycle of adjuvant chemotherapy; and at 3, 6, 9, and 12 months after randomization. Patient-reported QOL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) core questionnaire (EORTC-QLQ-C30), ovarian cancer questionnaire modules (QLQ-OV28), and the MD Anderson Symptoms Inventory (MDASI).
Results:
Of the 184 patients enrolled, 165 (83/92 in the HIPEC group and 82/92 in the control group) participated in the baseline QOL assessment. There were no statistically significant differences in functional scales and symptom scales in QLQ-C30; symptom scales, including gastrointestinal symptoms QLQ-OV28; and severity and impact score in MDASI between the 2 treatment groups until 12 months after randomization.
Conclusion
HIPEC with cytoreductive surgery showed no statistically significant difference in HRQOL outcomes. Thus, implementation of HIPEC during either primary or interval cytoreductive surgery does not impair HRQOL.
7.Effectiveness and Safety of Electroconvulsive Therapy in Clinical Practice.
Sung Woo JOO ; Ha Eun JEONG ; Myong Wuk CHON ; Yeon Ho JOO ; Chang Yoon KIM ; Jung Sun LEE
Journal of Korean Neuropsychiatric Association 2016;55(3):202-208
OBJECTIVES: There is little research on the practice and effectiveness of electroconvulsive therapy (ECT) in Korea. This study investigated the practice pattern, effectiveness, and safety of ECT. METHODS: This chart review study included electronic medical records of 180 patients treated with ECT between January 2007 and December 2013 at the Asan Medical Center. Symptomatic improvement was assessed using Clinical Global Impression (CGI) scale. Treatment response was defined as CGI improvement scale score of 2 or less. Re-hospitalization was used as an indicator of recurrence. Safety was assessed by spontaneous reports from patients. RESULTS: One hundred and eighty patients underwent 1539 sessions of modified ECT. Their most frequent diagnosis was major depressive disorder (n=74, 41.1%). The most common indication for ECT was poor response to medication (n=177, 75.3%). Treatment response rate was 66.9% in acute phase group and 63.8% in the patients with poor response to medication. The recurrence rate at six months after the end of the course was 29.6%. Memory impairment or amnesia was the most common adverse effect. CONCLUSION: There was a remarkable improvement following ECT in patients who responded poorly to medications, and most adverse effects were tolerable and temporary. The present study suggests that ECT could be a useful treatment option.
Amnesia
;
Chungcheongnam-do
;
Depressive Disorder, Major
;
Diagnosis
;
Electroconvulsive Therapy*
;
Electronic Health Records
;
Humans
;
Korea
;
Memory
;
Recurrence
8.The Relationship between Cognitive Decline and Psychopathology in Patients with Schizophrenia and Bipolar Disorder.
Moon Doo KIM ; Hye Jin SEO ; Hyunju YUN ; Young Eun JUNG ; Joon Hyuk PARK ; Chang In LEE ; Ji Hyun MOON ; Seong Chul HONG ; Bo Hyun YOON ; Won Myong BAHK
Clinical Psychopharmacology and Neuroscience 2015;13(1):103-108
OBJECTIVE: The primary goals of the present study were to assess intellectual function in participants with schizophrenia or bipolar disorder (BD) and to investigate the relationships between cognitive decline and the severity of each type of psychopathology. METHODS: The present study included 51 patients with schizophrenia and 42 with BD who were recruited from the psychiatry outpatient clinic of Jeju University Hospital between March 2011 and March 2014. The Korean Wechsler Adult Intelligence Scale (K-WAIS) was administered to each of the 93 participants, and they were categorized into two groups based on their current intelligence quotient (IQ) and their estimated premorbid IQ: severely impaired group (SIG) and mildly impaired group (MIG). The Minnesota Multiple Personality Inventory (MMPI) and the Brief Psychiatric Rating Scale (BPRS) were used to assess psychopathology. RESULTS: The SIG schizophrenia participants exhibited significantly higher scores on the frequent (F) and schizophrenia (Sc) subscales of the MMPI, but significantly lower scores on the correction (K) and psychopathic deviate (Pd) subscales compared with the MIG schizophrenia participants. Furthermore, the BPRS scores were significantly higher in the SIG schizophrenia participants relative to the MIG schizophrenia participants. The SIG BD participants had significantly higher F, masculinity-femininity (Mf), paranoia (Pa), and Sc but significantly lower Pd scores compared with the MIG BD participants. CONCLUSION: The present findings revealed a significant discrepancy between the estimated premorbid levels of cognitive function and current cognitive function in participants with schizophrenia or BD. Moreover, this discrepancy was correlated with severity of psychopathology in both groups.
Adult
;
Ambulatory Care Facilities
;
Bipolar Disorder*
;
Brief Psychiatric Rating Scale
;
Cognition
;
Humans
;
Intelligence
;
Minnesota
;
MMPI
;
Multiple Personality Disorder
;
Paranoid Disorders
;
Psychopathology*
;
Schizophrenia*
9.Vaginal Removal of the Pedunculated Submucous Myoma: Twisting-off Method.
Hee Jung GO ; Eun Kyeong BAEK ; You Sung LEE ; Chang Ho LEE ; Jae Duk KIM ; Ho Myong HWANG ; Jae Kyun DOO
Korean Journal of Obstetrics and Gynecology 2002;45(7):1155-1158
OBJECTIVE: To evaluate the efficacy of the twisting-off method in transvaginal removal of the pedunculated submucous myoma. METHODS: After paracervical block and vaginal dressing with Povidone iodine, the myoma was grasped at its widest diameter and twisted to avulse it from its attatchment. Several kinds of grasping instruments, ie. kelley clamp, tenaculum, ring forcep, was used. If there was bleeding from its detachment site, vaginal gauze or tampon was inserted for bleeding control. RESULTS: The procedure was perfomed successfully on all 33 patients (100%). In most patients, bleeding was scanty in amount. But in one patient, emergency hysterectomy was performed because of massive uterine bleeding. The myoma varied greatly in size. Largest volume was 62.24 cm3, and mean volume was 13.79 cm3. Pathology revealed classic leiomyomas in most cases. Some showed endocervical polyp or endometrial polyp. Follow up examination was done, and its mean interval was eighteen weeks and no patient was recurred. CONCLUSION: The transvaginal removal of pedunculated submucous myoma utilizing grasping instruments may be an effective and safe procedure and the complication is minimal. Twisting-off method was may be a safe alternative to abdominal myomectomy and hysterectomy. Reproductive capacity can be preserved, also.
Anesthesia, Obstetrical
;
Bandages
;
Emergencies
;
Follow-Up Studies
;
Hand Strength
;
Hemorrhage
;
Humans
;
Hysterectomy
;
Leiomyoma
;
Myoma*
;
Pathology
;
Polyps
;
Povidone-Iodine
;
Surgical Instruments
;
Uterine Hemorrhage
10.Non-steroidal anti-inflammatory drug with corticosteroid induced acute gut injury and bacterial translocation in rat.
Jeong Wook KIM ; Woo Kyu JEON ; Jae Hyuk DO ; Sae Kyung CHANG ; Eon Sub PARK ; Joon Sup YEOM ; Hyo Soon PARK ; Eun Jeong KIM ; Myong Suk SHIN
Korean Journal of Medicine 2005;68(4):369-377
BACKGROUND: Use of corticosteroid appears to increase the risk of upper gastrosintestinal side effects associated with NSAIDs. But, there is no study for the effects of these drugs to NSAID induced small intestinal damage. Therefore, we examed the effects of corticosteroid to NSAID induced enteropathy and bacterial translocation. METHODS: Rat received no drug, NSAID alone (diclofenac 80 mg/kg per os), corticosteroid alone (dexamethasone 5 mg/kg intraperitoneal, 2 times) or NSAID with corticosteroid. Amounts of food intakes, body weight, intestinal permeability, enteric aerobic bacterial counts in small and large intestine, serum biochemical profiles, and pathologic findings of ileum were measured. Cultures of the mesenteric lymph nodes, as well as liver, spleen and systemic blood were taken. RESULTS: Diclofenac or dexamethasone alone administration caused gut barrier damage, enteric bacterial overgrowth and increased bacterial translocation. The supplements with dexamethasone increased NSAID induced gut barrier damage, villous atrophy, enteric bacterial overgrowth and bacterial translocation to mesenteric lymph nodes, liver, spleen and systemic blood. Also, these increased diclofenac induced body weight loss, but not hypoproteinemia. CONCLUSION: Corticosteroid increase NSAID induced body weight loss, gut barrier dysfunction, villous atrophy, enteric bacterial overgrowth and bacterial translocation in experimental animals.
Animals
;
Anti-Inflammatory Agents, Non-Steroidal
;
Atrophy
;
Bacterial Load
;
Bacterial Translocation*
;
Body Weight
;
Dexamethasone
;
Diclofenac
;
Hypoproteinemia
;
Ileum
;
Intestine, Large
;
Intestine, Small
;
Liver
;
Lymph Nodes
;
Permeability
;
Rats*
;
Spleen